I agree with you that we will not see a PR on either Hema or Dcell. However I could see a PR with respects to REGEN. Putting out the date of the IPO and/or the opening price is possible. Also, stating that the IPO would take place some time in mid-September (just a guess guys) would then give BMSN time to release updates on both Hema and dCell within that time frame, along with any other unknowns such as grants or funding to create the necessary buzz for the imminent REGEN IPO. This would maximize the opening day price. We've already seen the August 1 PR placed upon many different cancer/stem cell related sights. REGEN's name is already getting out there. This is the time to load IMHO. GLTA NoQuarter
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.